Dana-Farber research reveals possible new target for treatment of sickle cell and beta thalassemia
That pathway involves BACH2 and NRF2 and was discovered using a large genome-wide association study that enabled an analysis of genes related to fetal hemoglobin from a wide range of ancestries, including European, African, and Asian ancestries.
Read original article on The Medical News →Related news
-
Medetomidine: The dangerous animal sedative turning up in Scotland's street drugs
United Kingdom
-
Candy-coated Lollylab checks saliva for medication
United Kingdom
-
Genetic links to ADHD, autism and depression changed with age
United Kingdom
-
Nonprofit Brings Free Music Education to More Than 20,000 Miami Students in 131 Schools
United Kingdom
-
Counting to 5 reveals how children's 'inner speech' develops
United Kingdom
-
Experts warn of dangers in consuming raw milk and dairy products
United Kingdom
-
Youth e-bike and e-scooter injuries rise nearly four-fold, study finds
United Kingdom
-
Doctors faced an AI-use penalty after disclosing AI use to patients
United Kingdom